Targeted therapies called MEK inhibitors are changing the treatment landscape for neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). NF1-PN are benign tumors that develop in the ...
Neurofibromatosis type 1 (NF1) is a genetic condition that raises your risk of tumors, including benign plexiform neurofibromas (PN), which grow along tissues that cover nerves. PN often can’t be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback